The heteromeric PC-1/PC-2 polycystin complex is activated by the PC-1 N-terminus

Mutations in the polycystin proteins, PC-1 and PC-2, result in autosomal dominant polycystic kidney disease (ADPKD) and ultimately renal failure. PC-1 and PC-2 enrich on primary cilia, where they are thought to form a heteromeric ion channel complex. However, a functional understanding of the putati...

Full description

Bibliographic Details
Main Authors: Kotdaji Ha, Mai Nobuhara, Qinzhe Wang, Rebecca V Walker, Feng Qian, Christoph Schartner, Erhu Cao, Markus Delling
Format: Article
Language:English
Published: eLife Sciences Publications Ltd 2020-11-01
Series:eLife
Subjects:
Online Access:https://elifesciences.org/articles/60684
_version_ 1811253151410421760
author Kotdaji Ha
Mai Nobuhara
Qinzhe Wang
Rebecca V Walker
Feng Qian
Christoph Schartner
Erhu Cao
Markus Delling
author_facet Kotdaji Ha
Mai Nobuhara
Qinzhe Wang
Rebecca V Walker
Feng Qian
Christoph Schartner
Erhu Cao
Markus Delling
author_sort Kotdaji Ha
collection DOAJ
description Mutations in the polycystin proteins, PC-1 and PC-2, result in autosomal dominant polycystic kidney disease (ADPKD) and ultimately renal failure. PC-1 and PC-2 enrich on primary cilia, where they are thought to form a heteromeric ion channel complex. However, a functional understanding of the putative PC-1/PC-2 polycystin complex is lacking due to technical hurdles in reliably measuring its activity. Here we successfully reconstitute the PC-1/PC-2 complex in the plasma membrane of mammalian cells and show that it functions as an outwardly rectifying channel. Using both reconstituted and ciliary polycystin channels, we further show that a soluble fragment generated from the N-terminal extracellular domain of PC-1 functions as an intrinsic agonist that is necessary and sufficient for channel activation. We thus propose that autoproteolytic cleavage of the N-terminus of PC-1, a hotspot for ADPKD mutations, produces a soluble ligand in vivo. These findings establish a mechanistic framework for understanding the role of PC-1/PC-2 heteromers in ADPKD and suggest new therapeutic strategies that would expand upon the limited symptomatic treatments currently available for this progressive, terminal disease.
first_indexed 2024-04-12T16:46:18Z
format Article
id doaj.art-aedf6706a94d481e92e4965e72048760
institution Directory Open Access Journal
issn 2050-084X
language English
last_indexed 2024-04-12T16:46:18Z
publishDate 2020-11-01
publisher eLife Sciences Publications Ltd
record_format Article
series eLife
spelling doaj.art-aedf6706a94d481e92e4965e720487602022-12-22T03:24:35ZengeLife Sciences Publications LtdeLife2050-084X2020-11-01910.7554/eLife.60684The heteromeric PC-1/PC-2 polycystin complex is activated by the PC-1 N-terminusKotdaji Ha0Mai Nobuhara1Qinzhe Wang2Rebecca V Walker3https://orcid.org/0000-0002-2473-4303Feng Qian4Christoph Schartner5Erhu Cao6Markus Delling7https://orcid.org/0000-0001-9556-2097Department of Physiology, University of California, San Francisco, San Francisco, United StatesDepartment of Physiology, University of California, San Francisco, San Francisco, United StatesDepartment of Biochemistry, University of Utah School of Medicine, Salt Lake City, United StatesDivision of Nephrology, Department of Medicine, University of Maryland School of Medicine, Baltimore, United StatesDivision of Nephrology, Department of Medicine, University of Maryland School of Medicine, Baltimore, United StatesDepartment of Physiology, University of California, San Francisco, San Francisco, United StatesDepartment of Biochemistry, University of Utah School of Medicine, Salt Lake City, United StatesDepartment of Physiology, University of California, San Francisco, San Francisco, United StatesMutations in the polycystin proteins, PC-1 and PC-2, result in autosomal dominant polycystic kidney disease (ADPKD) and ultimately renal failure. PC-1 and PC-2 enrich on primary cilia, where they are thought to form a heteromeric ion channel complex. However, a functional understanding of the putative PC-1/PC-2 polycystin complex is lacking due to technical hurdles in reliably measuring its activity. Here we successfully reconstitute the PC-1/PC-2 complex in the plasma membrane of mammalian cells and show that it functions as an outwardly rectifying channel. Using both reconstituted and ciliary polycystin channels, we further show that a soluble fragment generated from the N-terminal extracellular domain of PC-1 functions as an intrinsic agonist that is necessary and sufficient for channel activation. We thus propose that autoproteolytic cleavage of the N-terminus of PC-1, a hotspot for ADPKD mutations, produces a soluble ligand in vivo. These findings establish a mechanistic framework for understanding the role of PC-1/PC-2 heteromers in ADPKD and suggest new therapeutic strategies that would expand upon the limited symptomatic treatments currently available for this progressive, terminal disease.https://elifesciences.org/articles/60684primary ciliapolycystin channelsADPKDkidney
spellingShingle Kotdaji Ha
Mai Nobuhara
Qinzhe Wang
Rebecca V Walker
Feng Qian
Christoph Schartner
Erhu Cao
Markus Delling
The heteromeric PC-1/PC-2 polycystin complex is activated by the PC-1 N-terminus
eLife
primary cilia
polycystin channels
ADPKD
kidney
title The heteromeric PC-1/PC-2 polycystin complex is activated by the PC-1 N-terminus
title_full The heteromeric PC-1/PC-2 polycystin complex is activated by the PC-1 N-terminus
title_fullStr The heteromeric PC-1/PC-2 polycystin complex is activated by the PC-1 N-terminus
title_full_unstemmed The heteromeric PC-1/PC-2 polycystin complex is activated by the PC-1 N-terminus
title_short The heteromeric PC-1/PC-2 polycystin complex is activated by the PC-1 N-terminus
title_sort heteromeric pc 1 pc 2 polycystin complex is activated by the pc 1 n terminus
topic primary cilia
polycystin channels
ADPKD
kidney
url https://elifesciences.org/articles/60684
work_keys_str_mv AT kotdajiha theheteromericpc1pc2polycystincomplexisactivatedbythepc1nterminus
AT mainobuhara theheteromericpc1pc2polycystincomplexisactivatedbythepc1nterminus
AT qinzhewang theheteromericpc1pc2polycystincomplexisactivatedbythepc1nterminus
AT rebeccavwalker theheteromericpc1pc2polycystincomplexisactivatedbythepc1nterminus
AT fengqian theheteromericpc1pc2polycystincomplexisactivatedbythepc1nterminus
AT christophschartner theheteromericpc1pc2polycystincomplexisactivatedbythepc1nterminus
AT erhucao theheteromericpc1pc2polycystincomplexisactivatedbythepc1nterminus
AT markusdelling theheteromericpc1pc2polycystincomplexisactivatedbythepc1nterminus
AT kotdajiha heteromericpc1pc2polycystincomplexisactivatedbythepc1nterminus
AT mainobuhara heteromericpc1pc2polycystincomplexisactivatedbythepc1nterminus
AT qinzhewang heteromericpc1pc2polycystincomplexisactivatedbythepc1nterminus
AT rebeccavwalker heteromericpc1pc2polycystincomplexisactivatedbythepc1nterminus
AT fengqian heteromericpc1pc2polycystincomplexisactivatedbythepc1nterminus
AT christophschartner heteromericpc1pc2polycystincomplexisactivatedbythepc1nterminus
AT erhucao heteromericpc1pc2polycystincomplexisactivatedbythepc1nterminus
AT markusdelling heteromericpc1pc2polycystincomplexisactivatedbythepc1nterminus